BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.20), $0.11 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $33.8 million versus the consensus estimate of $31.61 million.

GUIDANCE:

BioLife Solutions sees FY2021 revenue of $115-119 million, versus the consensus of $114.4 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.